 | • レポートコード：MRC2-11QY13073 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は外陰部痛治療薬のグローバル市場について調査・分析したレポートです。種類別（局所麻酔薬、抗けいれん薬、三環系抗うつ薬、抗菌薬、ホルモンクリーム、神経ブロック、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別外陰部痛治療薬の競争状況、市場シェア ・世界の外陰部痛治療薬市場：種類別市場規模 2015年-2020年（局所麻酔薬、抗けいれん薬、三環系抗うつ薬、抗菌薬、ホルモンクリーム、神経ブロック、その他） ・世界の外陰部痛治療薬市場：種類別市場規模予測 2021年-2026年（局所麻酔薬、抗けいれん薬、三環系抗うつ薬、抗菌薬、ホルモンクリーム、神経ブロック、その他） ・世界の外陰部痛治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の外陰部痛治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の外陰部痛治療薬市場分析：米国、カナダ ・ヨーロッパの外陰部痛治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの外陰部痛治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の外陰部痛治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの外陰部痛治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer Inc、Sanofi Aventis、Eli Lilly and Company、Depomed Inc、Janssen Pharmaceuticals、Noven Pharmaceuticals、Upsher-Smith Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Vulvodynia Treatment Drugs Market
The global Vulvodynia Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Vulvodynia Treatment Drugs Scope and Market Size
Vulvodynia Treatment Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vulvodynia Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Vulvodynia Treatment Drugs market is segmented into
Local Anesthetics
Anticonvulsants
Tricyclic Antidepressants
Antimicrobials
Hormone Creams
Nerve Blocks
Others
Segment by Application, the Vulvodynia Treatment Drugs market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional and Country-level Analysis
The Vulvodynia Treatment Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Vulvodynia Treatment Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Vulvodynia Treatment Drugs Market Share Analysis
Vulvodynia Treatment Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vulvodynia Treatment Drugs business, the date to enter into the Vulvodynia Treatment Drugs market, Vulvodynia Treatment Drugs product introduction, recent developments, etc.
The major vendors covered:
Pfizer Inc
Sanofi Aventis
Eli Lilly and Company
Depomed Inc
Janssen Pharmaceuticals
Noven Pharmaceuticals
Upsher-Smith Laboratories
…
1 Study Coverage
1.1 Vulvodynia Treatment Drugs Product Introduction
1.2 Market Segments
1.3 Key Vulvodynia Treatment Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Vulvodynia Treatment Drugs Market Size Growth Rate by Type
1.4.2 Local Anesthetics
1.4.3 Anticonvulsants
1.4.4 Tricyclic Antidepressants
1.4.5 Antimicrobials
1.4.6 Hormone Creams
1.4.7 Nerve Blocks
1.4.8 Others
1.5 Market by Application
1.5.1 Global Vulvodynia Treatment Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Vulvodynia Treatment Drugs Market Size, Estimates and Forecasts
2.1.1 Global Vulvodynia Treatment Drugs Revenue 2015-2026
2.1.2 Global Vulvodynia Treatment Drugs Sales 2015-2026
2.2 Global Vulvodynia Treatment Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Vulvodynia Treatment Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Vulvodynia Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Vulvodynia Treatment Drugs Competitor Landscape by Players
3.1 Vulvodynia Treatment Drugs Sales by Manufacturers
3.1.1 Vulvodynia Treatment Drugs Sales by Manufacturers (2015-2020)
3.1.2 Vulvodynia Treatment Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Vulvodynia Treatment Drugs Revenue by Manufacturers
3.2.1 Vulvodynia Treatment Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Vulvodynia Treatment Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Vulvodynia Treatment Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Vulvodynia Treatment Drugs Revenue in 2019
3.2.5 Global Vulvodynia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Vulvodynia Treatment Drugs Price by Manufacturers
3.4 Vulvodynia Treatment Drugs Manufacturing Base Distribution, Product Types
3.4.1 Vulvodynia Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vulvodynia Treatment Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Vulvodynia Treatment Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Vulvodynia Treatment Drugs Market Size by Type (2015-2020)
4.1.1 Global Vulvodynia Treatment Drugs Sales by Type (2015-2020)
4.1.2 Global Vulvodynia Treatment Drugs Revenue by Type (2015-2020)
4.1.3 Vulvodynia Treatment Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Vulvodynia Treatment Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Vulvodynia Treatment Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Vulvodynia Treatment Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Vulvodynia Treatment Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Vulvodynia Treatment Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Vulvodynia Treatment Drugs Market Size by Application (2015-2020)
5.1.1 Global Vulvodynia Treatment Drugs Sales by Application (2015-2020)
5.1.2 Global Vulvodynia Treatment Drugs Revenue by Application (2015-2020)
5.1.3 Vulvodynia Treatment Drugs Price by Application (2015-2020)
5.2 Vulvodynia Treatment Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Vulvodynia Treatment Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Vulvodynia Treatment Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Vulvodynia Treatment Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Vulvodynia Treatment Drugs by Country
6.1.1 North America Vulvodynia Treatment Drugs Sales by Country
6.1.2 North America Vulvodynia Treatment Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Vulvodynia Treatment Drugs Market Facts & Figures by Type
6.3 North America Vulvodynia Treatment Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Vulvodynia Treatment Drugs by Country
7.1.1 Europe Vulvodynia Treatment Drugs Sales by Country
7.1.2 Europe Vulvodynia Treatment Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vulvodynia Treatment Drugs Market Facts & Figures by Type
7.3 Europe Vulvodynia Treatment Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Vulvodynia Treatment Drugs by Region
8.1.1 Asia Pacific Vulvodynia Treatment Drugs Sales by Region
8.1.2 Asia Pacific Vulvodynia Treatment Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Vulvodynia Treatment Drugs Market Facts & Figures by Type
8.3 Asia Pacific Vulvodynia Treatment Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Vulvodynia Treatment Drugs by Country
9.1.1 Latin America Vulvodynia Treatment Drugs Sales by Country
9.1.2 Latin America Vulvodynia Treatment Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Vulvodynia Treatment Drugs Market Facts & Figures by Type
9.3 Central & South America Vulvodynia Treatment Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Vulvodynia Treatment Drugs by Country
10.1.1 Middle East and Africa Vulvodynia Treatment Drugs Sales by Country
10.1.2 Middle East and Africa Vulvodynia Treatment Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Vulvodynia Treatment Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Vulvodynia Treatment Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Description and Business Overview
11.1.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc Vulvodynia Treatment Drugs Products Offered
11.1.5 Pfizer Inc Related Developments
11.2 Sanofi Aventis
11.2.1 Sanofi Aventis Corporation Information
11.2.2 Sanofi Aventis Description and Business Overview
11.2.3 Sanofi Aventis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Aventis Vulvodynia Treatment Drugs Products Offered
11.2.5 Sanofi Aventis Related Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Corporation Information
11.3.2 Eli Lilly and Company Description and Business Overview
11.3.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly and Company Vulvodynia Treatment Drugs Products Offered
11.3.5 Eli Lilly and Company Related Developments
11.4 Depomed Inc
11.4.1 Depomed Inc Corporation Information
11.4.2 Depomed Inc Description and Business Overview
11.4.3 Depomed Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Depomed Inc Vulvodynia Treatment Drugs Products Offered
11.4.5 Depomed Inc Related Developments
11.5 Janssen Pharmaceuticals
11.5.1 Janssen Pharmaceuticals Corporation Information
11.5.2 Janssen Pharmaceuticals Description and Business Overview
11.5.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Janssen Pharmaceuticals Vulvodynia Treatment Drugs Products Offered
11.5.5 Janssen Pharmaceuticals Related Developments
11.6 Noven Pharmaceuticals
11.6.1 Noven Pharmaceuticals Corporation Information
11.6.2 Noven Pharmaceuticals Description and Business Overview
11.6.3 Noven Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Noven Pharmaceuticals Vulvodynia Treatment Drugs Products Offered
11.6.5 Noven Pharmaceuticals Related Developments
11.7 Upsher-Smith Laboratories
11.7.1 Upsher-Smith Laboratories Corporation Information
11.7.2 Upsher-Smith Laboratories Description and Business Overview
11.7.3 Upsher-Smith Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Upsher-Smith Laboratories Vulvodynia Treatment Drugs Products Offered
11.7.5 Upsher-Smith Laboratories Related Developments
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Description and Business Overview
11.1.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc Vulvodynia Treatment Drugs Products Offered
11.1.5 Pfizer Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Vulvodynia Treatment Drugs Market Estimates and Projections by Region
12.1.1 Global Vulvodynia Treatment Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Vulvodynia Treatment Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Vulvodynia Treatment Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Vulvodynia Treatment Drugs Sales Forecast (2021-2026)
12.2.2 North America: Vulvodynia Treatment Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Vulvodynia Treatment Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Vulvodynia Treatment Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Vulvodynia Treatment Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Vulvodynia Treatment Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Vulvodynia Treatment Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Vulvodynia Treatment Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Vulvodynia Treatment Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Vulvodynia Treatment Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Vulvodynia Treatment Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Vulvodynia Treatment Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Vulvodynia Treatment Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Vulvodynia Treatment Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Vulvodynia Treatment Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Vulvodynia Treatment Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Vulvodynia Treatment Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Vulvodynia Treatment Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Vulvodynia Treatment Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Vulvodynia Treatment Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vulvodynia Treatment Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Vulvodynia Treatment Drugs Market Segments
Table 2. Ranking of Global Top Vulvodynia Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Vulvodynia Treatment Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Local Anesthetics
Table 5. Major Manufacturers of Anticonvulsants
Table 6. Major Manufacturers of Tricyclic Antidepressants
Table 7. Major Manufacturers of Antimicrobials
Table 8. Major Manufacturers of Hormone Creams
Table 9. Major Manufacturers of Nerve Blocks
Table 10. Major Manufacturers of Others
Table 11. Global Vulvodynia Treatment Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Vulvodynia Treatment Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 13. Global Vulvodynia Treatment Drugs Sales by Regions 2015-2020 (K Units)
Table 14. Global Vulvodynia Treatment Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Vulvodynia Treatment Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Vulvodynia Treatment Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 17. Global Vulvodynia Treatment Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Vulvodynia Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Vulvodynia Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vulvodynia Treatment Drugs as of 2019)
Table 20. Vulvodynia Treatment Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Vulvodynia Treatment Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Vulvodynia Treatment Drugs Price (2015-2020) (USD/Unit)
Table 23. Vulvodynia Treatment Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Vulvodynia Treatment Drugs Product Type
Table 25. Date of International Manufacturers Enter into Vulvodynia Treatment Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Vulvodynia Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 28. Global Vulvodynia Treatment Drugs Sales Share by Type (2015-2020)
Table 29. Global Vulvodynia Treatment Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Vulvodynia Treatment Drugs Revenue Share by Type (2015-2020)
Table 31. Vulvodynia Treatment Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 32. Global Vulvodynia Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 33. Global Vulvodynia Treatment Drugs Sales Share by Application (2015-2020)
Table 34. North America Vulvodynia Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 35. North America Vulvodynia Treatment Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Vulvodynia Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Vulvodynia Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Vulvodynia Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 39. North America Vulvodynia Treatment Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Vulvodynia Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 41. North America Vulvodynia Treatment Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Vulvodynia Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 43. Europe Vulvodynia Treatment Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Vulvodynia Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Vulvodynia Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Vulvodynia Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 47. Europe Vulvodynia Treatment Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Vulvodynia Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 49. Europe Vulvodynia Treatment Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Vulvodynia Treatment Drugs Sales by Region (2015-2020) (K Units)
Table 51. Asia Pacific Vulvodynia Treatment Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Vulvodynia Treatment Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Vulvodynia Treatment Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Vulvodynia Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 55. Asia Pacific Vulvodynia Treatment Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Vulvodynia Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 57. Asia Pacific Vulvodynia Treatment Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Vulvodynia Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 59. Latin America Vulvodynia Treatment Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Vulvodynia Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Vulvodynia Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Vulvodynia Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 63. Latin America Vulvodynia Treatment Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Vulvodynia Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 65. Latin America Vulvodynia Treatment Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Vulvodynia Treatment Drugs Sales by Country (2015-2020) (K Units)
Table 67. Middle East and Africa Vulvodynia Treatment Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Vulvodynia Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Vulvodynia Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Vulvodynia Treatment Drugs Sales by Type (2015-2020) (K Units)
Table 71. Middle East and Africa Vulvodynia Treatment Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Vulvodynia Treatment Drugs Sales by Application (2015-2020) (K Units)
Table 73. Middle East and Africa Vulvodynia Treatment Drugs Sales Market Share by Application (2015-2020)
Table 74. Pfizer Inc Corporation Information
Table 75. Pfizer Inc Description and Major Businesses
Table 76. Pfizer Inc Vulvodynia Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Pfizer Inc Product
Table 78. Pfizer Inc Recent Development
Table 79. Sanofi Aventis Corporation Information
Table 80. Sanofi Aventis Description and Major Businesses
Table 81. Sanofi Aventis Vulvodynia Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Sanofi Aventis Product
Table 83. Sanofi Aventis Recent Development
Table 84. Eli Lilly and Company Corporation Information
Table 85. Eli Lilly and Company Description and Major Businesses
Table 86. Eli Lilly and Company Vulvodynia Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Eli Lilly and Company Product
Table 88. Eli Lilly and Company Recent Development
Table 89. Depomed Inc Corporation Information
Table 90. Depomed Inc Description and Major Businesses
Table 91. Depomed Inc Vulvodynia Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Depomed Inc Product
Table 93. Depomed Inc Recent Development
Table 94. Janssen Pharmaceuticals Corporation Information
Table 95. Janssen Pharmaceuticals Description and Major Businesses
Table 96. Janssen Pharmaceuticals Vulvodynia Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Janssen Pharmaceuticals Product
Table 98. Janssen Pharmaceuticals Recent Development
Table 99. Noven Pharmaceuticals Corporation Information
Table 100. Noven Pharmaceuticals Description and Major Businesses
Table 101. Noven Pharmaceuticals Vulvodynia Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Noven Pharmaceuticals Product
Table 103. Noven Pharmaceuticals Recent Development
Table 104. Upsher-Smith Laboratories Corporation Information
Table 105. Upsher-Smith Laboratories Description and Major Businesses
Table 106. Upsher-Smith Laboratories Vulvodynia Treatment Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Upsher-Smith Laboratories Product
Table 108. Upsher-Smith Laboratories Recent Development
Table 109. Global Vulvodynia Treatment Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 110. Global Vulvodynia Treatment Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Vulvodynia Treatment Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Vulvodynia Treatment Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Vulvodynia Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 114. North America: Vulvodynia Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Vulvodynia Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 116. Europe: Vulvodynia Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Vulvodynia Treatment Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 118. Asia Pacific: Vulvodynia Treatment Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Vulvodynia Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 120. Latin America: Vulvodynia Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Vulvodynia Treatment Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 122. Middle East and Africa: Vulvodynia Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Vulvodynia Treatment Drugs Players
Table 127. Vulvodynia Treatment Drugs Customers List
Table 128. Vulvodynia Treatment Drugs Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Vulvodynia Treatment Drugs Product Picture
Figure 2. Global Vulvodynia Treatment Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Local Anesthetics Product Picture
Figure 4. Anticonvulsants Product Picture
Figure 5. Tricyclic Antidepressants Product Picture
Figure 6. Antimicrobials Product Picture
Figure 7. Hormone Creams Product Picture
Figure 8. Nerve Blocks Product Picture
Figure 9. Others Product Picture
Figure 10. Global Vulvodynia Treatment Drugs Sales Market Share by Application in 2020 & 2026
Figure 11. Hospital Pharmacy
Figure 12. Retail Pharmacy
Figure 13. Online Pharmacy
Figure 14. Vulvodynia Treatment Drugs Report Years Considered
Figure 15. Global Vulvodynia Treatment Drugs Market Size 2015-2026 (US$ Million)
Figure 16. Global Vulvodynia Treatment Drugs Sales 2015-2026 (K Units)
Figure 17. Global Vulvodynia Treatment Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Vulvodynia Treatment Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Vulvodynia Treatment Drugs Sales Market Share by Region in 2019
Figure 20. Global Vulvodynia Treatment Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Vulvodynia Treatment Drugs Revenue Market Share by Region in 2019
Figure 22. Global Vulvodynia Treatment Drugs Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Vulvodynia Treatment Drugs Revenue in 2019
Figure 24. Vulvodynia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Vulvodynia Treatment Drugs Sales Market Share by Type (2015-2020)
Figure 26. Global Vulvodynia Treatment Drugs Sales Market Share by Type in 2019
Figure 27. Global Vulvodynia Treatment Drugs Revenue Market Share by Type (2015-2020)
Figure 28. Global Vulvodynia Treatment Drugs Revenue Market Share by Type in 2019
Figure 29. Global Vulvodynia Treatment Drugs Market Share by Price Range (2015-2020)
Figure 30. Global Vulvodynia Treatment Drugs Sales Market Share by Application (2015-2020)
Figure 31. Global Vulvodynia Treatment Drugs Sales Market Share by Application in 2019
Figure 32. Global Vulvodynia Treatment Drugs Revenue Market Share by Application (2015-2020)
Figure 33. Global Vulvodynia Treatment Drugs Revenue Market Share by Application in 2019
Figure 34. North America Vulvodynia Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 35. North America Vulvodynia Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Vulvodynia Treatment Drugs Sales Market Share by Country in 2019
Figure 37. North America Vulvodynia Treatment Drugs Revenue Market Share by Country in 2019
Figure 38. U.S. Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. U.S. Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Canada Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Vulvodynia Treatment Drugs Market Share by Type in 2019
Figure 43. North America Vulvodynia Treatment Drugs Market Share by Application in 2019
Figure 44. Europe Vulvodynia Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Vulvodynia Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Vulvodynia Treatment Drugs Sales Market Share by Country in 2019
Figure 47. Europe Vulvodynia Treatment Drugs Revenue Market Share by Country in 2019
Figure 48. Germany Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Russia Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Vulvodynia Treatment Drugs Market Share by Type in 2019
Figure 59. Europe Vulvodynia Treatment Drugs Market Share by Application in 2019
Figure 60. Asia Pacific Vulvodynia Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 61. Asia Pacific Vulvodynia Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Vulvodynia Treatment Drugs Sales Market Share by Region in 2019
Figure 63. Asia Pacific Vulvodynia Treatment Drugs Revenue Market Share by Region in 2019
Figure 64. China Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. China Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Japan Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. South Korea Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. India Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Australia Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Taiwan Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Indonesia Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Thailand Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Malaysia Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Philippines Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 85. Vietnam Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Vulvodynia Treatment Drugs Market Share by Type in 2019
Figure 87. Asia Pacific Vulvodynia Treatment Drugs Market Share by Application in 2019
Figure 88. Latin America Vulvodynia Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 89. Latin America Vulvodynia Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Vulvodynia Treatment Drugs Sales Market Share by Country in 2019
Figure 91. Latin America Vulvodynia Treatment Drugs Revenue Market Share by Country in 2019
Figure 92. Mexico Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Mexico Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Brazil Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 97. Argentina Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Vulvodynia Treatment Drugs Market Share by Type in 2019
Figure 99. Latin America Vulvodynia Treatment Drugs Market Share by Application in 2019
Figure 100. Middle East and Africa Vulvodynia Treatment Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 101. Middle East and Africa Vulvodynia Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Vulvodynia Treatment Drugs Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Vulvodynia Treatment Drugs Revenue Market Share by Country in 2019
Figure 104. Turkey Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. Turkey Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. Saudi Arabia Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Vulvodynia Treatment Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 109. U.A.E Vulvodynia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Vulvodynia Treatment Drugs Market Share by Type in 2019
Figure 111. Middle East and Africa Vulvodynia Treatment Drugs Market Share by Application in 2019
Figure 112. North America Vulvodynia Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. North America Vulvodynia Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Vulvodynia Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Europe Vulvodynia Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Vulvodynia Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Asia Pacific Vulvodynia Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Vulvodynia Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Latin America Vulvodynia Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Vulvodynia Treatment Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 121. Middle East and Africa Vulvodynia Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…- 白血病治療薬の世界市場（～2026年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…
- 喘息治療薬の世界市場（～2026年） Market Analysis and Insights: Global Asthma Treatment Drugs Market The global Asthma Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Asthma Treatment Drugs Scope and Market Size Asthma Treatment Drugs m…
- 結核治療薬の世界市場（～2026年） Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes, or talks. Market Analysis and Insight…
- 緑内障治療薬の世界市場（～2026年） Market Analysis and Insights: Global Glaucoma Treatment Drugs Market The global Glaucoma Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Glaucoma Treatment Drugs Scope and Market Size Glaucoma Treatment…